Back to KRYS
Avoro Capital Advisors LLC → KRYS
Avoro Capital Advisors LLC KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
5
Latest value
$960.7M
Q3 2026
Peak value
$1.1B
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $712.2M |
| Q4 2025 | $712.2M |
| Q1 2026 | $746.3M |
| Q2 2026 | $1.1B |
| Q3 2026 | $960.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $960.7M | 2.89M | — | — |
| Q2 2026 | $1.1B | 2.89M | — | — |
| Q1 2026 | $746.3M | 2.89M | — | — |
| Q4 2025 | $712.2M | 2.89M | — | — |
| Q4 2025 | $712.2M | 2.89M | — | — |
Other funds holding KRYS
$1.2B
$1.1B
$1.1B
$857.3M
$814.4M
$774.3M
$733.8M
$702.3M